Avion Wealth Eli Lilly & CO Transaction History

Avion Wealth

$466 Million
Q3 2025

A detailed history of Avion Wealth transactions in Eli Lilly & CO stock. As of the latest transaction made, Avion Wealth holds 701 shares of LLY stock, worth $604,864. This represents 0.11% of its overall portfolio holdings.

Number of Shares

701

Previous 734 4.5%

Holding current value

$604,864

Previous $572,000 6.64%

% of portfolio

0.11%

Previous 0.13%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	SELL	$625.65 - $812.69 $20,646 - $26,818	-33 Reduced 4.5%	701 $534,000
Q2 2025 Jul 30, 2025	BUY	$713.71 - $898.95 $18,556 - $23,372	26 Added 3.67%	734 $572,000
Q2 2025 Jul 24, 2025	BUY	$713.71 - $898.95 $21,411 - $26,968	30 Added 4.42%	708 $584,000
Q4 2024 Jan 29, 2025	SELL	$727.2 - $932.06 $16,725 - $21,437	-23 Reduced 3.28%	678 $523,000
Q3 2024 Oct 18, 2024	BUY	$772.14 - $960.02 $6,177 - $7,680	8 Added 1.15%	701 $621,000
Q2 2024 Jul 26, 2024	BUY	$724.87 - $909.04 $13,047 - $16,362	18 Added 2.67%	693 $627,000
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $193,057 - $258,283	-326 Reduced 32.57%	675 $526,000
Q4 2023 Jan 26, 2024	SELL	$525.19 - $619.13 $27,835 - $32,813	-53 Reduced 5.03%	1,001 $584,000
Q3 2023 Oct 20, 2023	BUY	$434.7 - $599.3 $5,216 - $7,191	12 Added 1.15%	1,054 $565,000
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $11,925 - $15,945	34 Added 3.37%	1,042 $488,000
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $63,679 - $74,788	205 Added 25.53%	1,008 $368,000
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $15,330 - $17,999	55 Added 7.35%	803 $260,000
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $10,367 - $12,477	-76 Reduced 9.22%	748 $123,000
Q1 2020 Apr 08, 2020	BUY	$119.05 - $147.35 $98,097 - $121,416	824 New	824 $114,000

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

779M

Call Options Held

16.9M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $820B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.

Account